VivoSeq
Other

Post Partum Haemorrhage

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Post Partum Haemorrhage is an early-stage landscape with 0 programs across 1 company. The most active players are Baymatob Operations Pty Ltd.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

0/100

Attrition Rate

33/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

B

Baymatob Operations Pty Ltd

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

3

clinical trials

Terminated1 · 33%
Unknown status1 · 33%
Active, not recruiting1 · 33%

Clinical Trials

Trial Activity

Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage
Terminated·AAssistance Publique - Hôpitaux de Paris·Phase 4·NCT01113229·1,721 enrolled
Carbetocin Versus Ergometrine in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally
Unknown status·—·Phase 3·NCT02410759·200 enrolled
Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage, in Advance of Delivery/Birth
Active, not recruiting·BBaymatob Operations Pty Ltd·Preclinical·NCT06655207·1,000 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)